For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Etoricoxib | Etoricoxib 60 mg once a day (q.d.) | None | None | 6 | 500 | 82 | 500 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Peritoneal adhesion | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Bacterial infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Lung abscess, chest pain/tightness and tremor | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Traffic accident | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Urethritis | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Respiratory failure | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Edema , face/eye /hand/leg | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Dizziness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Abdominal distension / flatulence | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Abdominal pain, upper | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Hypertension / elevated blood pressure | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Palpitation | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Skin rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |